Susquehanna Private Capital (“SPC”), a middle market private equity firm, today announced an investment in Spherix Global Insights (“Spherix” or the “Company”), a leading pharmaceutical market insights firm focused on the dermatology, gastroenterology, nephrology, neurology, ophthalmology, and rheumatology specialties. Terms of the transaction were not disclosed.

Spherix Global Insights is a hyper-focused market intelligence firm that leverages our own independent data and expertise to provide strategic guidance, so biopharma stakeholders make decisions with confidence. We specialize in the dermatology, gastroenterology, nephrology, neurology, ophthalmology, and rheumatology markets.

Susquehanna Private Capital Announces Investment In Spherix Global Insights

Description

Company Information

Susquehanna Private Capital Announces Investment In Spherix Global Insights

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information